Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Celldex Therapeutics Inc (CLDX)
NASDAQ:CLDX
Celldex (CLDX) Stock Price & Analysis
878 Followers
CLDX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$25.19 - $48.40
Previous Close$25.45
Volume435.22K
Average Volume (3M)424.36K
Market Cap
$1.20B
Enterprise ValueN/A
Total Cash (Recent Filing)$252.70M
Total Debt (Recent Filing)$3.25M
Price to Earnings (P/E)-10.6
Beta1.19
Next Earnings
Nov 08, 2023EPS Estimate
-$0.68Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.40
Shares Outstanding47,260,804
10 Day Avg. Volume423,722
30 Day Avg. Volume424,361
Standard Deviation0.57
R-Squared0.04
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)4.96
Price to Sales (P/S)4627.33
Price to Cash Flow (P/CF)-11.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$56.20Price Target Upside120.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Celldex News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CLDX FAQ
What was Celldex Therapeutics Inc’s price range in the past 12 months?
Celldex Therapeutics Inc lowest stock price was $25.19 and its highest was $48.40 in the past 12 months.
What is Celldex Therapeutics Inc’s market cap?
Currently, no data Available
When is Celldex Therapeutics Inc’s upcoming earnings report date?
Celldex Therapeutics Inc’s upcoming earnings report date is Nov 08, 2023 which is in 45 days.
How were Celldex Therapeutics Inc’s earnings last quarter?
Celldex Therapeutics Inc released its earnings results on Aug 08, 2023. The company reported -$0.65 earnings per share for the quarter, beating the consensus estimate of -$0.658 by $0.008.
Is Celldex Therapeutics Inc overvalued?
According to Wall Street analysts Celldex Therapeutics Inc’s price is currently Undervalued.
Does Celldex Therapeutics Inc pay dividends?
Celldex Therapeutics Inc does not currently pay dividends.
What is Celldex Therapeutics Inc’s EPS estimate?
Celldex Therapeutics Inc’s EPS estimate is -$0.68.
How many shares outstanding does Celldex Therapeutics Inc have?
Celldex Therapeutics Inc has 47,260,803 shares outstanding.
What happened to Celldex Therapeutics Inc’s price movement after its last earnings report?
Celldex Therapeutics Inc reported an EPS of -$0.65 in its last earnings report, beating expectations of -$0.658. Following the earnings report the stock price went down -5.832%.
Which hedge fund is a major shareholder of Celldex Therapeutics Inc?
Among the largest hedge funds holding Celldex Therapeutics Inc’s share is Woodline Partners LP. It holds Celldex Therapeutics Inc’s shares valued at 2M.
---
Celldex Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$56.20 (120.83% Upside)
$56.20 (120.83% Upside)
Blogger Sentiment
Bullish
CLDX Sentiment 100%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 1.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 6.8%
Last 30 Days ▼ 6.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.57%
12-Months-Change
Fundamentals
Return on Equity
-35.21%
Trailing 12-Months
Asset Growth
-25.72%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Celldex Therapeutics Inc
Celldex Therapeutics, Inc. engages in the research, development, and commercialization of immunotherapies and other targeted biologics. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.
---
Top 5 ETFs holding CLDX
Vanguard Total Stock Market ETF
$41.31M
Vanguard Health Care ETF
$3.88M
Fidelity Nasdaq Composite Index ETF
$707.59K
Schwab U.S. Broad Market ETF
$648.97K
Vanguard Russell 3000 ETF
$80.69K
Up to five ETFs with an Outperform Smart Score that hold CLDX. The ETFs are listed according to market value of CLDX within the ETF
---